Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
International Journal of Oncology|February 16, 2017
PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cellsAmany Sayed Mawas, Vishwa Jeet Amatya, Rui Suzuki, et al.
Acute Medicine & Surgery|July 31, 2020
Statistical analysis of anti-mamushi venom serum injection time and clinical courseOsamu Okamoto, Takaoki Sato, Asako Todoroki, et al.
Histopathology|October 18, 2018
Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinomaYuichiro Kai, Vishwa J Amatya, Kei Kushitani, et al.
The American Journal of Surgical Pathology|June 5, 2020
SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung AdenocarcinomaTakahiro Kambara, Vishwa J Amatya, Kei Kushitani, et al.
Oncology Letters|February 23, 2018
Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasiaKei Kushitani, Vishwa Jeet Amatya, Amany Sayed Mawas, et al.
Translational Lung Cancer Research|March 15, 2021
Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lungYuichiro Kai, Vishwa Jeet Amatya, Kei Kushitani, et al.
Pageof 2